RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Mitchell Schaffler to Etidronic Acid

Back to Details
This is a "connection" page, showing publications Mitchell Schaffler has written about Etidronic Acid.
Mitchell Schaffler
Connection Strength
0.467
Etidronic Acid
  1. Yang Li C, Majeska RJ, Laudier DM, Mann R, Schaffler MB. High-dose risedronate treatment partially preserves cancellous bone mass and microarchitecture during long-term disuse. Bone. 2005 Sep; 37(3):287-95.
    View in: PubMed
    Score: 0.240
  2. Li CY, Price C, Delisser K, Nasser P, Laudier D, Clement M, Jepsen KJ, Schaffler MB. Long-term disuse osteoporosis seems less sensitive to bisphosphonate treatment than other osteoporosis. J Bone Miner Res. 2005 Jan; 20(1):117-24.
    View in: PubMed
    Score: 0.226
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support